Chonnam Med J. 2022 Jan;58(1):63-63. English.
Published online Jan 25, 2022.
© Chonnam Medical Journal, 2022
Case Report

Implantable Cardioverter-Defibrillator Lead in an Explanted Human Heart

Hyung Ki Jeong,1 and Namsik Yoon2
    • 1Division of Cardiology, Department of Internal Medicine, Wonkwang University Hospital, Wonkwang University School of Medicine, Iksan, Korea.
    • 2Division of Cardiology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Received October 22, 2021; Revised November 07, 2021; Accepted November 09, 2021.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

A 64-year-old man who had suffered from ischemic cardiomyopathy underwent heart transplantation. He had undergone a coronary intervention for myocardial infarction 3 years earlier. His left ventricular systolic function had gradually decreased, and he had received an implantable cardioverter defibrillator (ICD) 6 months earlier for the primary prevention of sudden cardiac death. The right ventricle (RV) of the explanted failing heart was dissected. After the RV free-wall dissection, the ICD lead was visible. The lead body adhered to the tricuspid valve leaflets, and the tip was fixed near the RV apex (Fig. 1A). The fibrotic change in the RV septum was assumed to be related to the mechanical irritation of the endocardium by the ICD lead. The lead tip was embedded via fibrotic encapsulation (Fig. 1B), which often renders the lead extraction challenging. Adhesion between ICD lead and cardiovascular structures occurs usually at the venous entry, SVC and cardiac chamber. The images show two of three frequent lead adhesion sites.1, 2 The intergrity and reliability of cardiac implantable devices are important to perform life-sustaining therapies. Therefore, leads must tolerate the physical stress of cardiac contraction and biological environment in the cardiovascular system. In this context, lead design has continuously improved. However, many studies have reported substantial rates of leads failure.3 This case showed how the leads of implantable cardiac devices adhered to caridovacular system and the results of the mechanical irritation of the leads in the heart. In addition, when lead failure occurred, this image warned that simply pulling leads out would be very dangerous potentially resulting in catastrophy such as RV invagination, large venous system tearing, or cardiac rupture because of adhesion to near structures

FIG. 1
After dissection of right ventricle free-wall, the ICD lead was visible. The lead body adhered to the tricuspid valve leaflets, and the tip was fixed near the right ventricle apex (A). The fibrotic change in the right ventricular septum was assumed to be related to the mechanical irritation of the endocardium by the ICD lead. The lead tip was embedded by fibrotic encapsulation (B), which often renders the lead extraction challenging.

Notes

CONFLICT OF INTEREST STATEMENT:None declared.

References

    1. Diemberger I, Mazzotti A, Giulia MB, Cristian M, Matteo M, Letizia ZM, et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices 2013;10:551–573.
    1. Smith HJ, Fearnot NE, Byrd CL, Wilkoff BL, Love CJ, Sellers TD. Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol 1994;17(11 Pt 2):2016–2020.
    1. Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, et al. Transvenous implantable cardioverter-defibrillator (ICD) lead performance: a meta-analysis of observational studies. J Am Heart Assoc 2015;4:e002418

Metrics
Share
Figures

1 / 1

PERMALINK